A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata
Public ClinicalTrials.gov record NCT03899259. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo- Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The reason for this study is to see if baricitinib is safe and effective in adults with severe or very severe alopecia areata (AA).
Study identification
- NCT ID
- NCT03899259
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 606 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 7, 2019
- Primary completion
- Jan 23, 2021
- Completion
- Nov 18, 2024
- Last update posted
- Apr 6, 2026
2019 – 2024
United States locations
- U.S. sites
- 33
- U.S. states
- 20
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Total Skin and Beauty Dermatology Center, PC | Birmingham | Alabama | 35205 | — |
| Investigate MD | Scottsdale | Arizona | 85255 | — |
| Center For Dermatology Clinical Research, Inc. | Fremont | California | 94538 | — |
| Quest Dermatology Research | Northridge | California | 91324 | — |
| Kaiser Permanente Hospital | San Francisco | California | 94118 | — |
| New England Research Associates | Bridgeport | Connecticut | 06606 | — |
| Florida Academic Centers Research and Education, LLC | Coral Gables | Florida | 33134 | — |
| New Horizon Research Center | Miami | Florida | 33165 | — |
| ForCare Clinical Research | Tampa | Florida | 33613-1244 | — |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis | Indiana | 46250 | — |
| The South Bend Clinic Center for Research | South Bend | Indiana | 46617 | — |
| Qualmedica Research, LLC | Owensboro | Kentucky | 42303 | — |
| Dermatology and Skin Cancer Specialists | Rockville | Maryland | 20850 | — |
| Tufts Medical Center | Boston | Massachusetts | 02111 | — |
| Great Lakes Research Group, Inc. | Bay City | Michigan | 48706 | — |
| Clinical Research Institute of Michigan, LLC | Chesterfield | Michigan | 48047 | — |
| Hamzavi Dermatology | Fort Gratiot | Michigan | 48059 | — |
| Associated Skin Care Specialists | New Brighton | Minnesota | 55112 | — |
| MediSearch Clinical Trials | Saint Joseph | Missouri | 64506 | — |
| Joseph J. Schwartz, M.D. | Troy | New York | 12180 | — |
| The University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27516 | — |
| Dermatology Specialists of Charlotte | Charlotte | North Carolina | 28211 | — |
| M3-Emerging Medical Research | Raleigh | North Carolina | 27612 | — |
| Bexley Dermatology Research | Bexley | Ohio | 43209 | — |
| University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106 | — |
| Dermatologists of Southwest Ohio | Mason | Ohio | 45040 | — |
| Vital Prospects Clinical Research Institute, P.C. | Tulsa | Oklahoma | 74136 | — |
| Northwest Dermatology Institute | Portland | Oregon | 97210 | — |
| Oregon Dermatology and Research Center | Portland | Oregon | 97210 | — |
| Velocity Clinical Research, Providence | East Greenwich | Rhode Island | 02818 | — |
| Suzanne Bruce and Associates, PA | Houston | Texas | 77056 | — |
| Progressive Clinical Research | San Antonio | Texas | 78213 | — |
| Virginia Clinical Research, Inc. | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 63 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03899259, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 6, 2026 · Synced Sep 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03899259 live on ClinicalTrials.gov.